Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$4.56B |
| 2 |
Intel
INTC
|
+$2.34B |
| 3 |
Union Pacific
UNP
|
+$1.18B |
| 4 |
Norfolk Southern
NSC
|
+$992M |
| 5 |
Wells Fargo
WFC
|
+$789M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$817M |
| 2 |
Amazon
AMZN
|
+$782M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$618M |
| 4 |
Altria Group
MO
|
+$610M |
| 5 |
Intuit
INTU
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.14% |
| 2 | Technology | 12.09% |
| 3 | Industrials | 11.31% |
| 4 | Communication Services | 11.1% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$222B
| $14.3B | 4.7% |
93,139,648
-42,427
| -0% | -$6.8M |
|
2
Gilead Sciences
GILD
$165B
| $11.7B | 3.85% |
99,991,520
-977,740
| -1% | -$107M |
|
|
3
Alphabet (Google) Class C
GOOG
$4.32T
| $8.29B | 2.72% |
313,093,040
+170,288,183
| +119% | +$4.56B |
|
4
Verizon
VZ
$196B
| $8.17B | 2.68% |
175,249,677
+3,262,000
| +2% | +$160M |
|
|
5
Amazon
AMZN
$2.96T
| $6.43B | 2.11% |
296,352,700
-37,416,000
| -11% | -$782M |
|
6
Philip Morris
PM
$295B
| $6.26B | 2.06% |
78,109,313
-4,205,360
| -5% | -$346M |
|
7
Oracle
ORCL
$423B
| $5.97B | 1.96% |
148,135,118
+12,064,000
| +9% | +$523M |
|
8
AbbVie
ABBV
$435B
| $5.57B | 1.83% |
82,969,218
-7,484,916
| -8% | -$489M |
|
9
Texas Instruments
TXN
$261B
| $4.96B | 1.63% |
96,196,948
-4,335,844
| -4% | -$239M |
|
|
10
Altria Group
MO
$114B
| $4.91B | 1.61% |
100,366,416
-12,037,187
| -11% | -$610M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.76B | 1.56% |
26,333,741
+1,570,549
| +6% | +$271M |
|
12
Netflix
NFLX
$309B
| $4.29B | 1.41% |
457,627,240
-45,399,270
| -9% | -$380M |
|
13
General Dynamics
GD
$106B
| $3.54B | 1.16% |
24,996,204
+468,332
| +2% | +$65M |
|
|
PCP
14
DELISTED
PRECISION CASTPARTS CORP
PCP
| $3.47B | 1.14% |
17,366,540
| – | – |
|
|
15
Union Pacific
UNP
$174B
| $3.42B | 1.12% |
35,846,522
+11,299,260
| +46% | +$1.18B |
|
16
Home Depot
HD
$355B
| $3.28B | 1.08% |
29,511,621
-608,200
| -2% | -$68.1M |
|
17
UnitedHealth
UNH
$370B
| $3.24B | 1.07% |
26,580,463
-675,486
| -2% | -$79.9M |
|
18
Accenture
ACN
$108B
| $3.18B | 1.05% |
32,858,903
-2,174,300
| -6% | -$208M |
|
19
AT&T
T
$163B
| $3.02B | 0.99% |
112,420,937
+1,026,100
| +0.9% | +$26.5M |
|
20
Stryker
SYK
$130B
| $3B | 0.98% |
31,359,233
+3,360,000
| +12% | +$318M |
|
21
Crown Castle
CCI
$32.2B
| $2.93B | 0.96% |
36,462,436
+3,911,300
| +12% | +$326M |
|
|
22
Intel
INTC
$513B
| $2.75B | 0.9% |
90,408,500
+72,268,500
| +398% | +$2.34B |
|
23
CSX Corp
CSX
$93.1B
| $2.72B | 0.9% |
250,251,906
+8,721,000
| +4% | +$101M |
|
24
BioMarin Pharmaceuticals
BMRN
$12.4B
| $2.69B | 0.88% |
19,637,821
+143,705
| +0.7% | +$17.8M |
|
25
Canadian Natural Resources
CNQ
$93.8B
| $2.68B | 0.88% |
204,504,411
+24,205,277
| +13% | +$364M |
|
Similar funds
Capital Research Global Investors's Q2 2015 Portfolio in Review
As of Q2 2015, Capital Research Global Investors held 466 positions worth $304B, up 4.2% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors deployed $10.5B of net new capital in Q2 2015, opening 26 new positions and adding to 162 existing holdings. Its largest new stake was Enbridge: 11,185,165 shares worth $523M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Johnson Controls International, an estimated $817M trimmed.
- Capital Research Global Investors's largest Q2 2015 buy was Enbridge: 11,185,165 shares worth $523M.
- Capital Research Global Investors added most to Alphabet (Google) Class C in Q2 2015, an estimated $4.56B increase.
- Capital Research Global Investors's biggest Q2 2015 reduction was Johnson Controls International, cutting an estimated $817M.
- Capital Research Global Investors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $618M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $304B portfolio in Q2 2015.
- Capital Research Global Investors opened 26 new positions and closed 33 in Q2 2015.
- Capital Research Global Investors's portfolio value rose 4.2% quarter-over-quarter to $304B.
Based on Capital Research Global Investors's 13F filing for Q2 2015, filed 14 Aug 2015.